Summary
April 2007, Vol. 3, No. 2, Pages 235-249 , DOI 10.1517/17425255.3.2.235

Whole-body physiologically based pharmacokinetic models

Ivan Nestorov
Zymogenetics Inc., 1201 Eastlake Avenue East, Seattle, Washington 98102, USAE-mail: intv@zgi.com



This review summarizes the most recent developments in and applications of physiologically based pharmacokinetic (PBPK) modeling methodology originating from both the pharmaceutical and environmental toxicology areas. It focusses on works published in the last 5 years, although older seminal papers have also been referenced. After a brief introduction to the field and several essential definitions, the main body of the text is structured to follow the major steps of a typical PBPK modeling exercise. Various applications of the methodology are briefly described. The major future trends and perspectives are outlined. The main conclusion from the review of the available literature is that PBPK modeling, despite its obvious potential and recent incremental developments, has not taken the place it deserves, especially in pharmaceutical and drug development sciences.

Full Text | PDF (224 KB) | PDF Plus (478 KB)

Forward Links to Citing Articles

Donald E. MAGER, Sukyung WOO, William J. JUSKO. (2009) Scaling Pharmacodynamics from In Vitro and Preclinical Animal Studies to Humans. Drug Metabolism and Pharmacokinetics 24:1, 16-24
Online publication date: 1-Feb-2009.
CrossRef
Masoud JAMEI, Gemma L DICKINSON, Amin ROSTAMI-HODJEGAN. (2009) A Framework for Assessing Inter-individual Variability in Pharmacokinetics Using Virtual Human Populations and Integrating General Knowledge of Physical Chemistry, Biology, Anatomy, Physiology and Genetics: A Tale of ‘Bottom-Up’ vs ‘Top-Down’ Recognition of Covariates. Drug Metabolism and Pharmacokinetics 24:1, 53-75
Online publication date: 1-Feb-2009.
CrossRef
Stefan Willmann. (2009) Das In-silico-Child . Können Computer-Simulationen klinisch-pharmakokinetische Studien ersetzen?. Pharmazie in unserer Zeit 38:1, 62-67
Online publication date: 1-Feb-2009.
CrossRef
F. Bouzom, B. Walther. (2009) Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling. Fundamental & Clinical Pharmacology 22:6, 579-587
Online publication date: 1-Jan-2009.
CrossRef
Andrea N Edginton, Frank-Peter Theil, Walter Schmitt, Stefan Willmann. (2008) Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Expert Opinion on Drug Metabolism & Toxicology 4:9, 1143-1152
Online publication date: 1-Sep-2008.
Summary | Full Text | PDF (313 KB) | PDF Plus (271 KB) 
Kok-Yong Seng, Ivan Nestorov, Paolo Vicini. (2008) Physiologically Based Pharmacokinetic Modeling of Drug Disposition in Rat and Human: A Fuzzy Arithmetic Approach. Pharmaceutical Research 25:8, 1771-1781
Online publication date: 1-Sep-2008.
CrossRef
Sheila Annie Peters. (2008) Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Lineshape Analysis. Clinical Pharmacokinetics 47:4, 261-275
Online publication date: 1-Feb-2008.
CrossRef
Stefan S De Buck, Claire E Mackie. (2007) Physiologically based approaches towards the prediction of pharmacokinetics: in vitro–in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 3:6, 865-878
Online publication date: 1-Dec-2007.
Summary | Full Text | PDF (234 KB) | PDF Plus (423 KB) 
T. Lavé, N. Parrott, H. P. Grimm, A. Fleury, M. Reddy. (2007) Challenges and opportunities with modelling and simulation in drug discovery and drug development. Xenobiotica 37:10-11, 1295-1310
Online publication date: 1-Nov-2007.
Summary | Full Text | PDF (232 KB) | PDF Plus (294 KB) 
K. Sandy Pang, Michael Weiss, Panos Macheras. (2007) Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts. The AAPS Journal 9:2, E268-E283
Online publication date: 1-Jul-2007.
CrossRef

Users who read this article also read:

Whole body physiologically-based pharmacokinetic models: their use in clinical drug development
Andrea N Edginton, Frank-Peter Theil, Walter Schmitt, Stefan Willmann
Expert Opinion on Drug Metabolism & Toxicology, Sep 2008, Vol. 4, No. 9, Pages 1143-1152.
Summary | Full Text | PDF (313 KB) | PDF Plus (271 KB) | Add to Favorites | Related 
 

Prev. Article | Next Article
View/Print PDF (224 KB)
View PDF Plus (478 KB)
Add to favourite
Email to a friend
TOC Alert | Citation Alert What is RSS?

 
 
Quick Search
for 
Author:
Ivan Nestorov
Keywords:
drug development
environmental toxicology
model
pharmacodynamics
physiologically based pharmacokinetics
risk analysis